We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Sphere Medical

Sphere Medical develops medical monitoring and diagnostic equipment, including the CE-marked Proxima platform for mea... read more Featured Products: More products

Download Mobile App




CE-Marked Blood Analyzer Interfaces with Popular Data Management System

By LabMedica International staff writers
Posted on 12 Sep 2016
Print article
Image: The Proxima blood gas analysis system can be connected into LIS and data management systems of Conworx (Photo courtesy of Sphere Medical).
Image: The Proxima blood gas analysis system can be connected into LIS and data management systems of Conworx (Photo courtesy of Sphere Medical).
Unique point-of-care (POC) connectivity to a widely used information transfer and management system is now available for a novel in-line arterial blood analyzer that supports rapid and frequent measurement of blood gases, electrolytes, and metabolites to monitor critical care patients without leaving bedside.

The CE-marked Proxima blood analysis device from Sphere Medical (Cambridgeshire UK) can now be connected into the family of laboratory information system interfaces and data management solutions from Conworx Technology (Berlin, Germany). This is a significant development since it provides near real-time feedback and ensures seamless transfer of test results from Proxim directly into laboratory information management systems (LIMSs) and electronic patient records – a key requirement for the successful implementation of POC testing.

Proxima supports patient critical care, including in the ICU and OR. The device sensor is a miniaturized blood gas analyzer integrated directly into the patient’s arterial line so that analyzed blood is returned to the patient. A dedicated bedside monitor with touch screen interface also provides simple, clear user-guiding routines.

With the new software drivers, users will be able to directly import diagnostics data from Proxima at patient bedside into Conworx’s POCcelerator, UniPOC middleware data management systems. In addition, the new interface will allow direct connectivity into CliniSys, a LIMS, through the CliniSys PoCT Solutions interface.

Both Conworx and CliniSys software solutions are being used in many hospitals globally, which would help ensure that data transfer from Proxima can be easily implemented, and its use and performance readily monitored remotely. Conworx’s middleware solutions provide connectivity, management, and integration for over 150 different POCT device types, as well as all relevant information and patient record systems. The Conworx base currently includes 1800 hospitals in 25 countries, and CliniSys software systems are used in over 2500 laboratories in 35 countries.

Sphere Medical CEO, Wolfgang Rencken, said: “This presents a huge step forward into integrating data from Proxima into laboratory information systems and electronic patient records. Partnering with Conworx allows our customers to use one middleware solution for all of their POC connectivity needs and greatly simplifies the implementation of Proxima within the hospital.”

Conworx CEO, Roman Rosenkranz, said: “We are delighted to be able to offer the first interface to an ex-vivo analyzer, which provides a seamless connection from the patient right through to the laboratory information system.”

Related Links:
Sphere Medical
Conworx Technology
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.